Plus234Feed

Neimeth International Pharmaceuticals Q1 2026 Board Meeting Outcome

Neimeth International Pharmaceuticals Plc has disclosed that its Board of Directors, at a meeting held on 28th April 2026, approved the company's Unaudited Financial Statements for the first quarter ended 31st March 2026. The filing confirms the statements will be submitted to the Nigerian Exchange Limited on or before 30th April 2026.

Plus234Feed summary based on reporting from Plus234Feed Intelligence. Read the original report below.

Read full article

Continue on Plus234Feed Intelligence

Visit
Share